Literature DB >> 8580829

CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth.

S M Lens1, R de Jong, R Q Hintzen, G Koopman, R A van Lier, R H van Oers.   

Abstract

Members of the Tumour Necrosis Factor-Receptor (TNFR) family play an essential role in the control of lymphoid cell growth and differentiation. The ligand of one of its lymphoid-specific members, CD27, was recently characterized as CD70, a type II transmembrane molecule with homology to TNF that is expressed on activated T and B cells. Ligation of CD27 by its natural ligand generates a potent costimulatory signal for cytokine production and proliferation of activated T cells. In contrast to normal B cells, where CD27 expression is confined to germinal centre cells and to a small subset of circulating B lymphocytes, CD27 expression is found on a large array of distinct B-cell neoplasia. Here, we review recent data on the expression and function of TNFR family members on normal and malignant lymphocytes and propose a role for CD27-CD70 interaction in B-cell development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580829     DOI: 10.3109/10428199509064922

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody.

Authors:  B F Israel; R J Pickles; D M Segal; R D Gerard; S C Kenney
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.

Authors:  Natalia Kovalova; Rance Nault; Robert Crawford; Timothy R Zacharewski; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2016-11-30       Impact factor: 4.219

3.  Stemness of B-cell progenitors in multiple myeloma bone marrow.

Authors:  Kelly Boucher; Nancy Parquet; Raymond Widen; Kenneth Shain; Rachid Baz; Melissa Alsina; John Koomen; Claudio Anasetti; William Dalton; Lia E Perez
Journal:  Clin Cancer Res       Date:  2012-09-17       Impact factor: 12.531

4.  Extraosseous (extramedullary) plasmacytomas: a clinicopathologic and immunophenotypic study of 32 Chinese cases.

Authors:  Zhuo Zuo; Yuan Tang; Cheng-Feng Bi; Wen-Yan Zhang; Sha Zhao; Xiao-Qing Wang; Qun-Pei Yang; Li-Qun Zou; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-12-19       Impact factor: 2.644

5.  CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.

Authors:  P J Adam; J A Terrett; G Steers; L Stockwin; J A Loader; G C Fletcher; L-S Lu; B I Leach; S Mason; A C Stamps; R S Boyd; F Pezzella; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2006-08-07       Impact factor: 7.640

Review 6.  The CD70-CD27 axis in oncology: the new kids on the block.

Authors:  Tal Flieswasser; Astrid Van den Eynde; Jonas Van Audenaerde; Jorrit De Waele; Filip Lardon; Carsten Riether; Hans de Haard; Evelien Smits; Patrick Pauwels; Julie Jacobs
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.